ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Actinium Completes Enrollment of Second Dose Cohort in Actimab-A Venetoclax Combination Trial
April 02, 2021Actinium Pharmaceuticals announced that initial patient enrollment in the second dose cohort in the Phase 1 portion of the Actimab-A venetoclax Phase 1/2 combination trial in fit and unfit patients with relapsed or refractory Acute Myeloid Leukemia ... -
Actinium Announces Actimab-A Plus 7+3 Combination Trial for AML
March 05, 2020Actinium Pharmaceuticals is expanding its CD33 program studying Actimab-A into a combination trial with the chemotherapy regimen 7+3 in patients with newly diagnosed acute myeloid leukemia (AML) ...
Pharma Sources Insight January 2025
